Vis enkel innførsel

dc.contributor.authorMalicki, Stanislawen_US
dc.contributor.authorKsiazek, Miroslawen_US
dc.contributor.authorMajewski, Pawelen_US
dc.contributor.authorPecak, Aleksandraen_US
dc.contributor.authorMydel, Piotr Mateuszen_US
dc.contributor.authorGrudnik, Przemyslawen_US
dc.contributor.authorDubin, Grzegorzen_US
dc.date.accessioned2020-03-18T12:02:10Z
dc.date.available2020-03-18T12:02:10Z
dc.date.issued2019
dc.PublishedMalicki S, Ksiazek, Majewski, Pecak, Mydel PM, Grudnik, Dubin. Development of a novel, high-affinity ssDNA trypsin inhibitor. Journal of enzyme inhibition and medicinal chemistry (Print). 2019;34(1):638-643eng
dc.identifier.issn1475-6366
dc.identifier.issn1475-6374
dc.identifier.urihttps://hdl.handle.net/1956/21525
dc.description.abstractInhibitors of serine proteases are not only extremely useful in the basic research but are also applied extensively in clinical settings. Using Systematic Evolution of Ligands by Exponential Enrichment (SELEX) approach we developed a family of novel, single-stranded DNA aptamers capable of specific trypsin inhibition. Our most potent candidate (T24) and its short version (T59) were thoroughly characterised in terms of efficacy. T24 and T59 efficiently inhibited bovine trypsin with Ki of 176 nM and 475 nM, respectively. Interestingly, in contrast to the majority of known trypsin inhibitors, the selected aptamers have superior specificity and did not interact with porcine trypsin or any human proteases tested. These included plasmin and thrombin characterised by trypsin-like substrate specificity. Our results demonstrate that SELEX may be successfully employed in the development of potent and specific DNA based protease inhibitors.en_US
dc.language.isoengeng
dc.publisherTaylor & Franciseng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0eng
dc.titleDevelopment of a novel, high-affinity ssDNA trypsin inhibitoren_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2019-12-06T10:38:53Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2019 The Author(s)
dc.identifier.doihttps://doi.org/10.1080/14756366.2019.1569648
dc.identifier.cristin1711723
dc.source.journalJournal of enzyme inhibition and medicinal chemistry (Print)


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY